Centaur, Inc.

Form 483 issued February 1, 2024 · Olathe, Kansas

Inspection
Jan 29 – Feb 1, 2024
Investigator
Conner N. Mann
Observations
2
Pages
4
FEI number
1931750

In short: On February 1, 2024, FDA issued a Form 483 with 2 observations to Centaur, Inc. in Olathe, Kansas (FEI 1931750) after an inspection that ran Jan 29 – Feb 1, 2024. The investigator was Conner N. Mann. Most observations concern quality system and materials; the most-cited regulation is 21 CFR 211.192 (production record review).

At a glance

Quality system and materials account for 2 of 2 observations.

Quality system1
Materials1

Most cited: 21 CFR 211.192 (1×) · 211.80(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review any unexplained discrepancy and the failure of a batch…

  2. 02

    Written procedures are lacking which describe in sufficient detail…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Centaur, Inc.?

FDA listed 2 observations on this Form 483, mostly about quality system and materials. The most-cited regulation is 21 CFR 211.192 (production record review). The opening words of each observation are shown on this page.

Who inspected Centaur, Inc.?

Conner N. Mann is named on this Form 483, for the inspection of Jan 29 – Feb 1, 2024. Each investigator has a profile showing what they cite most.

When was Centaur, Inc. inspected by FDA?

The inspection ran Jan 29 – Feb 1, 2024, and the Form 483 is dated February 1, 2024.

How do I get the full Form 483 for Centaur, Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free